Zylstra et al., 1986 - Google Patents
Membrane-associated glycoprotein (gp160) identified on human lung tumors by a monoclonal antibodyZylstra et al., 1986
View PDF- Document ID
- 12136725186043591191
- Author
- Zylstra S
- Chen F
- Ghosh S
- Repasky E
- Rao U
- Takita H
- Bankert R
- Publication year
- Publication venue
- Cancer research
External Links
Snippet
Abstract A monoclonal antibody (5E8) has been used to identify and structurally characterize a previously unreported macromolecule present on the surface of human lung tumors. This antibody was derived from a hybrid clone that was produced using spleen cells of mice …
- 210000004072 Lung 0 title abstract description 90
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/574—Immunoassay; Biospecific binding assay for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/531—Production of immunochemical test materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
- A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
- A61K47/48369—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the modifying part being an antibody, an immunoglobulin, or a fragment thereof, e.g. a Fc-fragment
- A61K47/48507—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the modifying part being an antibody, an immunoglobulin, or a fragment thereof, e.g. a Fc-fragment the modifying agent being a well defined antibody or immunoglobulin bearing at least one antigen-binding site
- A61K47/48515—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the modifying part being an antibody, an immunoglobulin, or a fragment thereof, e.g. a Fc-fragment the modifying agent being a well defined antibody or immunoglobulin bearing at least one antigen-binding site not used; see subgroups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/44—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2589682B2 (en) | Monoclonal antibodies and antigens for human non-bottom- ▼ small cell lung cancer | |
KR910000956B1 (en) | Monoclonal antibodies and antigen for human non-small cell lung carcinomas | |
KR900007951B1 (en) | Hybridomas producing monoclonal antibodies to new mucin epitopes | |
JP4122050B2 (en) | Human carcinoma antigen (HCA), HCA antibody, HCA immunoassay, imaging method and therapy | |
Milenic et al. | Construction, binding properties, metabolism, and tumor targeting of a single-chain Fv derived from the pancarcinoma monoclonal antibody CC49 | |
Zylstra et al. | Membrane-associated glycoprotein (gp160) identified on human lung tumors by a monoclonal antibody | |
US5185432A (en) | Monoclonal antibodies and antigen for human non-small cell lung carcinoma and other certain human carcinomas | |
US4737579A (en) | Monoclonal antibodies for human non-small cell lung carinomas | |
JPH04502702A (en) | Novel monoclonal antibodies against human cancer | |
JPS62501955A (en) | Monoclonal antibody for human non-small cell lung cancer | |
CN101679485A (en) | Functional epitope of osteopontin, monoclonal antibody aiming at osteopontin and application of monoclonal antibody | |
Temponi et al. | Binding parameters and idiotypic profile of the whole immunoglobulin and Fab'fragments of murine monoclonal antibody to distinct determinants of the human high molecular weight-melanoma associated antigen | |
JP2555028B2 (en) | Monoclonal antibody for human non-small cell lung cancer | |
EP0363703B1 (en) | Method of producing human-human hybridomas, the production of monoclonal and polyclonal antibodies therefrom, and therapeutic use thereof | |
US6004761A (en) | Method for detecting cancer using monoclonal antibodies to new mucin epitopes | |
Podolsky et al. | Emergence of antigenic glycoprotein structures in ulcerative colitis detected through monoclonal antibodies | |
WO1997030173A1 (en) | Monoclonal antibody that recognizes antigens present on the surface of endothelial cell of tumor vessel | |
JOHNSON et al. | Monoclonal antibody L/1C2 reactive with a human carcinoma associated antigen | |
JPH02500405A (en) | Monoclonal paratopic molecule against human ganglioside GD2 | |
JPS62500699A (en) | Monoclonal antibodies against human cancer tumor-associated antigens |